Fortrea Cuts FY24 Revenue Outlook From $3.14B-$3.205B To $2.785B-$2.855B, Est $3.08B

Benzinga · 4d ago
Planned divestiture of assets relating to the Endpoint Clinical and Patient Access businesses on track, the company said.